Cargando…

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

BACKGROUND: We modelled the efficiency of a personalised approach to screening for prostate and breast cancer based on age and polygenic risk-profile compared with the standard approach based on age alone. METHODS: We compared the number of cases potentially detectable by screening in a population u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pashayan, N, Duffy, S W, Chowdhury, S, Dent, T, Burton, H, Neal, D E, Easton, D F, Eeles, R, Pharoah, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093360/ https://www.ncbi.nlm.nih.gov/pubmed/21468051 http://dx.doi.org/10.1038/bjc.2011.118

Ejemplares similares

Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2015)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Incorporating genomics into breast and prostate cancer screening: assessing the implications
por: Chowdhury, Susmita, et al.
Publicado: (2013)

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles
por: Cybulski, C, et al.
Publicado: (2013)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
por: Ahmed, Mahbubl, et al.
Publicado: (2016)

Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2016)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
por: Benusiglio, P R, et al.
Publicado: (2006)

Utility of polygenic embryo screening for disease depends on the selection strategy
por: Lencz, Todd, et al.
Publicado: (2021)

Polygenic risk scores: An overview from bench to bedside for personalised medicine
por: Cross, Benjamin, et al.
Publicado: (2022)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
por: Maier, C, et al.
Publicado: (2005)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Can education be personalised using pupils’ genetic data?
por: Morris, Tim T, et al.
Publicado: (2020)

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
por: Saunders, Edward J, et al.
Publicado: (2016)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine
por: Bonter, Katherine, et al.
Publicado: (2011)

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
por: Sodha, N, et al.
Publicado: (2002)

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues
por: Hall, A.E., et al.
Publicado: (2014)

Interactions between genes involved in the antioxidant defence system and breast cancer risk
por: Oestergaard, M Z, et al.
Publicado: (2006)

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
por: Lesueur, F, et al.
Publicado: (2006)

Nomograms of human hippocampal volume shifted by polygenic scores
por: Janahi, Mohammed, et al.
Publicado: (2022)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Variable prediction accuracy of polygenic scores within an ancestry group
por: Mostafavi, Hakhamanesh, et al.
Publicado: (2020)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

Public health genomics and personalized prevention: lessons from the COGS project
por: Pashayan, N, et al.
Publicado: (2013)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Relationship between rice farming and polygenic scores potentially linked to agriculture in China
por: Zhu, Chen, et al.
Publicado: (2021)

An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome
por: Richardson, Tom G, et al.
Publicado: (2019)

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
por: Leongamornlert, D, et al.
Publicado: (2014)

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
por: Akbari, M R, et al.
Publicado: (2014)

GWAS of three molecular traits highlights core genes and pathways alongside a highly polygenic background
por: Sinnott-Armstrong, Nasa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b22dlu4edramoc3m5nch7gg83d